Current data suggest that the rate of breastfeeding in the United States is far below the recommendation of the American Academy of Pediatrics that all infants be exclusively breastfed for the first 6 ...

TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce ...

Formulating fixed-dose combination drugs proves more complex than simply adding one ingredient to another. Fixed-dose combination (FDC) drugs offer a number of benefits to drug manufacturers, patients ...

April 6, 2007 — Results of 2 randomized studies assessing a fixed-dose tablet combining sumatriptan and naproxen ( Trexima, Pozen Inc/GlaxoSmithKline) suggest that the combination offers more ...

The Company's intellectual property now covers the combination, formulation, and method of use of PrimeC Patent protection extends through 2042, adding four additional years to PrimeC's IP umbrella ...

Wu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations ...

Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide. (Image Credits: Pixabay) Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a ...

PHOENIX--(BUSINESS WIRE)--PanTheryx, an integrative digestive and immune health company, today announced the expansion of its formulation capabilities to now include colostrum plus probiotic ...

Acrux (ASX: ACR) -- The Australian drug delivery company, today announced positive results from its Phase 1 clinical studies using two unique contraceptive skin sprays, each containing a progestin and ...

“Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

It is estimated that approximately half of patients take their medications improperly. In the United States alone, adherence problems result in estimated costs of up to $100 billion annually. This is ...